• Users Online: 807
  • Home
  • Print this page
  • Email this page


 
 Table of Contents  
REVIEW
Year : 2015  |  Volume : 4  |  Issue : 1  |  Page : 7-17

Nontuberculous mycobacteria in Middle East: Current situation and future challenges


1 Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois at Chicago, USA

Date of Web Publication21-Feb-2017

Correspondence Address:
Mehdi Mirsaeidi
Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine M/C 719, University of Illinois at Chicago, 840 S. Wood St., Chicago, IL 60612-7323
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.1016/j.ijmyco.2014.12.005

Rights and Permissions
  Abstract 


Nontuberculous mycobacteria (NTM) are a diverse group of bacterial species that are distributed in the environment. Many of these environmental bacteria can cause disease in humans. The identification of NTM in environmental sources is important for both clinical and epidemiological purposes. In this study, the distribution of NTM species from environmental and clinical samples in the Middle East was reviewed. In order to provide an overview of NTM, as well as recent epidemiological trends, all studies addressing NTM in the Middle East from 1984 to 2014 were reviewed.
A total of 96 articles were found, in which 1751 NTM strains were isolated and 1084 of which were obtained from clinical samples, 619 from environmental samples and 48 were cited by case reports.
Mycobacterium fortuitum was the most common rapid growing mycobacteria (RGM) isolated from both clinical (269 out of 447 RGM; 60.1%) and environmental (135 out of 289 RGM; 46.7%) samples. Mycobacterium avium complex (MAC) was the most common slow growing mycobacteria (SGM) isolated from clinical samples (140 out of 637 SGM; 21.9%). An increasing trend in NTM isolation from the Middle East was noted over the last 5 years. This review demonstrates the increasing concern regarding NTM disease in the Middle East, emphasizing the need for regional collaboration and coordination in order to respond appropriately.

Keywords: Nontuberculous mycobacteria (NTM), Middle East, Environmental samples, Clinical samples


How to cite this article:
Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M. Nontuberculous mycobacteria in Middle East: Current situation and future challenges. Int J Mycobacteriol 2015;4:7-17

How to cite this URL:
Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M. Nontuberculous mycobacteria in Middle East: Current situation and future challenges. Int J Mycobacteriol [serial online] 2015 [cited 2019 Jul 18];4:7-17. Available from: http://www.ijmyco.org/text.asp?2015/4/1/7/200593




  Introduction Top


Nontuberculous mycobacteria (NTM) have been recognized as a diverse group of organisms that are ubiquitous in environmental sources [1]. In most regions of the world, NTM are not reportable public health diseases, so epidemiological data are not easily available [2]. However, data in published studies note increasing trends in the rate of NTM isolation from different geographic regions in the world. Increasing NTM isolation may have important public health implications [3]. Exposure to these organisms can cause serious infections in both immunocompetent and immunocompromised individuals [4]. According to the latest report released by WHO, about 35.3 million people in the world are living with HIV/AIDS, which represents one of the most vulnerable populations to NTM infection, as well as a higher risk for complications and poor disease outcomes [5]. Those receiving immunosuppressive therapy secondary to organ transplantation, cancer, autoimmune disease and those with diabetes mellitus may also be more susceptible to NTM as compared with the general population, as well as suffer more severe diseases. The incidence of NTM infections is growing all over the world. Although countries in the Middle East have increasingly reported NTM diseases [6], no comprehensive study of NTM distribution has been conducted in this region. The purpose of this review is to piece together clinical and environmental NTM data reported in peer-reviewed published literature in Middle Eastern countries over the last 30 years.


  Methods Top


Literature search strategy

This study was conducted by reviewing published literature from the Middle East using PubMed and Scopus for NTM during the study period 1984–2014 using search terms “atypical mycobacteria” [MeSH] AND “Middle East” [MeSH] OR “nontuberculous mycobacteria” [MeSH] AND “Middle East” [MeSH] OR “environmental mycobacteria” [MeSH] AND “Middle East” [MeSH].

Inclusion and exclusion criteria

Original articles that presented cross-sectional or cohort studies and reported the incidence of NTM in the Middle East were considered. Congress abstracts and studies using non-standard methods were excluded.

Data extraction and definitions

For all studies, the following data were extracted: year of publication, study setting, studies enroll time, and number of patients investigated. Inconsistencies between the reviewers were discussed to obtain consensus.

Data collection

The present study search strategy aimed to identify all available published studies that reported data on the incidence of NTM in the Middle East. A total of 379 articles were identified.

Although 298 irrelevant subjects were excluded, after full text evaluation, 96 papers (original and case report articles) describing the incidence of NTM in the Middle East countries were selected for analysis.

Countries included in the study

Countries were divided in two groups: Middle East countries and Eastern neighbors of Iran (Afghanistan, Pakistan). Data were provided from 11 countries, including Iran (34 articles) [7],[8],[9],[10],[11],[12],[13],[14],[15],[16],[17],[18],[19],[20],[21],[22],[23],[24],[25],[26],[27],[28],[29],[30],[31],[32],[33],[34],[35],[36],[37],[38],[39],[40], Turkey (21 articles) [41],[42],[43],[44],[45],[46],[47],[48],[49],[50],[51],[52],[53],[54],[55],[56],[57],[58],[59],[60],[61], Saudi Arabia (18 articles) [62],[63],[64],[65],[66],[67],[68],[69],[70],[71],[72],[73],[74],[75],[76],[77],[78],[79], Lebanon (5 articles) [80],[81],[82],[83],[84] Qatar (4 articles) [85],[86],[87],[88] Pakistan (4 articles) [89],[90],[91],[92] Iraq (3 articles) [93],[94],[95] Egypt (2 articles) [96],[97], Bahrain (2 articles) [98],[99], Kuwait (2 article) [100],[101], and Oman (1 article) [102]. No NTM data was reported in the remaining Middle Eastern countries, including Jordan, the United Arab Emirates, Syria, Yemen and Afghanistan.


  Results Top


Out of the 96 articles identified in the search, 48 were original articles and the remaining were case reports. From 48 original articles, 20 studies were conducted in Iran and 13 in Turkey. The remaining reports were obtained from Pakistan (3), Lebanon (3), Saudi Arabia (3), Iraq (3), Egypt (1), Kuwait (1) and Oman (1).

In total, 1751 NTM strains were isolated from the original studies and case reports during the study period. Among the 1751 NTM isolates, 1084 were obtained from clinical samples, 619 from environmental samples and 48 were cited by case reports. The majority of NTM strains were isolated from respiratory specimens, followed by skin lesions, urogenital and cerebrospinal fluid. According to included studies, identification of NTM by conventional techniques were the most frequently used methods.

NTM in clinical samples

Out of the 1084 isolated strains from the clinical original studies, 434 (40.0%) were reported from Iran, 280 (25.8%) from Turkey, 137 (12.6%) from Saudi Arabia, 116 (10.7%) from Pakistan, 47 (4.3%) from Egypt, 43 (3.9%) from Lebanon, 14 (1.2%) from Kuwait and 13 (1.1%) from Oman ([Table 1]). Among the 1084 NTM isolates from clinical samples, 637 (58.7%) were categorized as slow growing Mycobacterium (SGM) and 447 (41.2%) were rapidly growing Mycobacterium (RGM). The most common SGM in clinical samples was Mycobacterium avium complex (MAC) (140 out of 637; 21.9%). The SGM were found in 245 (56.4%) out of 434 NTM isolates of clinical samples from Iran, 177 (63.2%) out of 280 NTM isolates from Turkey, 47 (34.3%) out of 137 NTM isolates from Saudi Arabia and 69 (59.4%) out of 116 NTM isolates from Pakistan.
Table 1: Species distribution of clinical NTM isolated in articles reported from the Middle East.

Click here to view


The most common RGM isolated from clinical samples was Mycobacterium fortuitum (269 out of 447 RGM; 60.1%). M. fortuitum was found in 136 (71.9%) out of 189 RGM isolates from Iran, 49 (54.4%) out of 90 from Saudi Arabia, 48 (46.6%) out of 103 from Turkey, and 23 (48.9%) out of 47 from Pakistan. The species of the most common NTM isolates, the source of isolation and the country of origin are shown in [Table 2].
Table 2: The most frequently clinical NTM species in articles of the Middle East.

Click here to view


NTM in environmental samples

A total of 619 environmental NTM isolates were reported from studies from the Middle East in the last 30 years. Of these isolates, 330 (53.3%) NTM species were SGM and 289 (46.6%) were RGM. Out of 619, 271 (43.7%) isolates were reported from Iran, 271 (43.7%) from Iraq, 62 (10.0%) from Turkey and 15 (2.4%) from Saudi Arabia ([Table 3]).
Table 3: Species distribution of environmental NTM in articles reported from the Middle East.

Click here to view


The most common SGM by country was as follows: Mycobacterium flavescens in Iran (44 out of 271 SGM; 16.2%), Mycobacterium lentiflavum in Turkey (20 out of 62 SGM; 32.2%) and MAC in Iraq (40 out of 271 SGM; 14.7%) ([Table 3]).

A total of 289 NTM isolates were considered belonging to RGM. The most common RGM isolated from environmental samples was M. fortuitum (135; 46.7%), followed by Mycobacterium chelonae (91; 31.4%) and Mycobacterium abscessus (39; 13.4%).

As shown in [Table 4], the most common NTM isolated from soil and water samples was M. fortuitum. [Table 5] shows the frequency of the most RGM and SGM in different countries. There was no information available regarding environmental NTM from Israel, Pakistan, Egypt and Lebanon.
Table 4: The predominant NTM species found in environmental specimens.

Click here to view
Table 5: The most RGM and SGM in the Middle East countries.

Click here to view


Case report

A total of 48 case reports of NTM were published from Middle Eastern countries, including 15 (31.2%) from Saudi Arabia, 14 (29.1%) from Iran, 8 (16.6%) from Turkey, 4 (8.3%) from Qatar, and the remaining from Lebanon, Bahrain, Pakistan, Kuwait and Egypt ([Table 6]). The case reports were published during the study period beginning in the year 2000 through 2014. The isolated NTM species and infected organs in the case report articles are shown in [Table 6].
Table 6: Case report articles of the Middle East countries.

Click here to view


Trends of NTM isolates

Together, 1751 NTM isolates were reported in the Middle East, including 1084 isolates from clinical samples, 619 from environmental samples and 48 from the case reports. The highest number of NTM was isolated from Iran and Turkey. The distribution of published clinical and environmental data is shown in [Figure 1]. Also, according to this study, there was an increasing trend in the number of NTM from clinical samples. Before 2000, less than 100 NTM isolates were reported from the Middle East countries. In the following years, the total number of NTM isolates increased rapidly in this region, showing a rise in the number of NTM reports.
Figure 1: Distribution of published clinical and environmental data from the Middle East countries.

Click here to view



  Discussion Top


NTM infections are an increasing public health problem in many countries in the world. These environmental bacteria are capable of causing serious illnesses in both immunocompetent and immunocompromised individuals [103]. The relatively few studies addressing this growing public health problem in the Middle Eastern countries is also a concern. Lack of awareness among physicians and microbiologists, limited laboratory facilities and the already overwhelmed health systems from other endemic diseases are possible explanations for the lack of NTM data in the Middle East. The absence of information regarding the distribution of NTM poses significant challenges for infection control strategies [104]. Therefore, understanding the trends and true prevalence of NTM is one of the major priorities to optimize infection control programs and resources.

This study is the first review from the Middle Eastern countries describing the identification of NTM species from clinical and environmental samples. The increasing trends of NTM prevalence are notable in this study, which has important public health, healthcare system and policy implications in the region. For example, the similar clinical presentation of NTM to the well-established tuberculosis (TB) presents unique challenges in diagnosis and management. NTM can be easily misdiagnosed as TB and multidrug-resistant TB, resulting in inappropriate management. Misdiagnosis and delay in diagnosis of NTM can lead to serious morbidity and mortality [105],[106].

Different methods were used for the identification of NTM in many countries. Most laboratories use conventional methods. In more recent reports, improved molecular methods resulted in the ability to identify more NTM species [107]. National laboratories still need to standardize NTM protocols for diagnostic methods and management in most Middle Eastern countries.

Among the 1,084 NTM isolates from clinical samples in the Middle East, 58.7% were SGM and 41.2% were RGM. MAC and M. fortuitum were the most SGM and RGM, respectively. M. fortuitum is widely distributed in soil and water [108],[109]. This organism was first identified by Da Costa Cruz isolated from a skin abscess in 1938 [110]. The clinical presentation of M. fortuitum includes various clinical manifestations, including most commonly skin and soft-tissue infections [111]. The clinical diagnosis of RGM is difficult due to the absence of biochemical features [112]. The prevalence of M. fortuitum in European countries has been reported previously in Belgium (2.1%), the Czech Republic (17.5%), Denmark (5.3%), Finland (6.7%), France (6.5%), Germany (12.2%), Italy (2.5%), Portugal (16.5%), Spain (10.8%), Switzerland (17.5%), Turkey (33.9%), and the United Kingdom (6.0%) [112],[113]. M. fortuitum was the most common RGM found in Iran and Turkey [114]. According to this analysis, M. fortuitum was the most common species among the clinical isolates in the Middle East countries, including Iran.

SGM contain highly pathogenic species. MAC is a pathogen that may cause pulmonary disease, particularly in elderly women [115]. Disseminated MAC disease may occur in immunocompromised patients, particularly HIV-infected persons. It is estimated that more than 500,000 people living in the Middle East are infected with HIV [116]. Therefore, it could be speculated that MAC infection could increase in the Middle East in the near future. Studies suggest that the prevalence of MAC has increased in the United States, Europe and South Korea [83]. Mycobacterium simiae is another SGM that lives in the environment; tap water is thought to be the main source of this Mycobacterium [117]. M. simiae has been identified in various countries, such as France, Germany and Thailand, but most isolates have come from the Southern United States, Cuba and Israel [114],[118],[119].

Based on this review, M. simiae was the second most prevalent SGM in clinical samples ([Table 1]). The majority of M. simiae strains were reported from Iran. Baghaei et al. recently reviewed 26 Persian patients with pulmonary M. simiae infection from a national referral TB hospital.

The third most common SGM in clinical isolates in the Middle East was Mycobacterium kansasii. Clinical and antigenic characteristics of M. kansasii make it the most similar bacteria to MTB. The geographic areas with the highest reported cases of M. kansasii are the central and southern states of the United States, England, Wales and mining areas from Continental Europe, mainly in the Czech Republic [120]. In Spain, the most frequent NTM pulmonary disease is caused by M. kansasii. [121].

Mycobacterium gordonae was isolated from 9.4% of clinical samples ([Table 1]). The isolation of M. gordonae from environmental samples suggests that it may cause colonization and contamination of clinical samples [114],[122]. True infections with M. gordonae rarely occurs.

Mycobacterium xenopi belongs to a group of SGM that is widely distributed in various regions of Europe and Canada, but it is an uncommon pathogen of pulmonary disease in Asia [123],[124],[125],[126]. Identification of M. xenopi has increased globally during a 20-year period [127]. In the present study, M. xenopi was the most frequently isolated SGM from clinical samples from Pakistan.

The present review indicates that the NTM incidence is rising in most geographical areas in the Middle East. The increasing number of NTM infections in Iraq, Saudi Arabia, Turkey and Iran may be caused by the increasing awareness of NTM and improvements in diagnosis methods [128]. It is also possible that people in these countries are more susceptible to NTM infection.

Regarding environmental NTM, this review revealed that M. fortuitum (21.8%), M. chelonae (14.7%) and MAC (7.9%) were the most common species. The rapidly growing organisms, such as M. chelonae and M. fortuitum, are common in the environment and in hospital settings [129],[130],[131]. RGM are extremely resistant to antibiotics, antiseptics and disinfectants and, consequently, are significant nosocomial pathogens. Surgical procedures, accidental trauma or injections are also considered as risk factors for infections involving these organisms [129].

Similar to clinical samples, M. fortuitum was the most common species among RGM species obtained from environmental samples ([Table 3]). This finding strengthens the hypothesis that M. fortuitum is transmitted from nature to humans. Consequently, the probability of NTM transmission from person to person should be questioned. Among SGM isolates, MAC was the most common and M. flavescens placed second in environmental samples.


  Conclusion Top


The number of NTM isolates has significantly increased in the Middle East. There is an increasing concern about NTM disease in the Middle East, and regional collaboration and coordination is needed to respond to it appropriately.


  Conflict of interests Top


The authors have no conflicts of interests to declare related to this manuscript.


  Acknowledgements Top


This study was supported by the Mycobacteriology Research Center of Masih Daneshvari Hospital. The authors would like to send their appreciation to Dr. Marybeth Allen for her great editorial comments. Mehdi Mirsaeidi MD is supported by NIH grant 5 T32 HL 82547-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.



 
  References Top

1.
J.O. Falkinham, Nontuberculous mycobacteria in the environment, Clin. Chest Med. 23 (3) (2002) 529–551.  Back to cited text no. 1
    
2.
P.M. Cassidy, K. Hedberg, A. Saulson, E. McNelly, K.L. Winthrop, Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology, Clin. Infect. Dis. 49 (12) (2009) 124–129.  Back to cited text no. 2
    
3.
M.J. Miguez-Burbano, M. Flores, D. Ashkin, A. Rodriguez, A.M. Granada, N. Quintero, Non-tuberculous mycobacteria disease as a cause of hospitalization in HIV-infected subjects, Int. J. Infect. dis. 10 (1) (2006) 47–55.  Back to cited text no. 3
    
4.
V.M. Katoch, Infections due to non-tuberculous mycobacteria (NTM), Indian J. Med. Res. 120 (4) (2004) 290–304.  Back to cited text no. 4
    
5.
WHO, 2014, www.WHO.int/gov/HIV/en/, Global Health Observatory (GHO).  Back to cited text no. 5
    
6.
S. Simons, J. van Ingen, P.R. Hsueh, N.V. Hung, P.N.R.Dekhuijzen, et al, Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia, Emerg. Infect. Dis. 17 (3) (2011) 343–349.  Back to cited text no. 6
    
7.
F. Fallah, A. Karimi, G. Eslami, H. Goudarzi, M. Sharifian, F. Jadali, et al, Isolation of Mycobacterium and other microorganisms from skin infections in children during Bam earthquake, Iranian J. Clin. Infect. Dis. 2 (4) (2007) 185– 188.  Back to cited text no. 7
    
8.
E. Ghaemi, K. Ghazisaidi, H. Koohsari, B. Khodabakhshi, A. Mansoorian, Environmental mycobacteria in areas of high and low tuberculosis prevalence in the Islamic Republic of Iran, East. Mediterr. Health J. 12 (3/4) (2006) 280–285.  Back to cited text no. 8
    
9.
A. Hashemi-Shahraki, D. Darban-Sarokhalil, P. Heidarieh, M.M. Feizabadi, S.H. Deshmir-Salameh, et al, Mycobacterium simiae: a Possible Emerging Pathogen in Iran, Jpn. J. Infect. Dis. 66 (6) (2013) 475–479.  Back to cited text no. 9
    
10.
F. Heidari, P. Farnia, J. Noroozi, A. Majd, E. Tajedin, et al, The Rapid identification of atypical Mycobacterium in pulmonary tuberculosis (PTB) patients: evaluation of QUB3232 Locus using the VNTR Method (Text in Persian), J. Zanjan. Univ. Med. Sci. 17 (67) (2009) 33–44.  Back to cited text no. 10
    
11.
A.D. Khosravi, S. Seghatoleslami, M. Hashemzadeh, Application of PCR-Based fingerprinting for detection of nontuberculous mycobacteria among patients referred to tuberculosis reference center of Khuzestan Province, Iran, Res. J. Microbiol. 4 (4) (2009) 143.  Back to cited text no. 11
    
12.
S.H. Moghim, B. Nasr-Esfahani, N. Hosseini, E. Sarikhani, J. Faghri, T. Narimani, et al, Identification of non tuberculous mycobacteria isolated from Isfahan different water sources using phenotypic characterization tests (text in Persian), J. Water Wastewater 25 (86) (2012) 88–95.  Back to cited text no. 12
    
13.
N. Naderi, E. Alavi-Naini, B. Sharifi-Mood, M. Naserfar, Prevalence of tuberculosis and non tuberculosis Mycobacterium in Zahedan, Southeast of Iran, Res. J. Microbiol. 1 (4) (2006) 375–377.  Back to cited text no. 13
    
14.
B. Nasr-Esfahani, E. Sarikhani, S. Moghim, J. Faghri, H. Fazeli, et al, Molecular characterization of environmental nontuberculous mycobacteria using PCR- RFLP analysis of 441 Bp heat shock protein 65 fragments, Iran. J. Public Health 41 (4) (2012) 108–114.  Back to cited text no. 14
    
15.
T. Radaei, B. Nasr-Esfahani, H. Gasemian-Safaei, S.H. Moghim, H. Fazeli, J. Faghri, et al, Ethambutol-susceptibility of clinical and environmental atypical mycobacteria isolated from Isfahan, Iran (text in Persian), J. Isfahan Med. School 31 (234) (2013) 1–7.  Back to cited text no. 15
    
16.
M. Rahbar, A. Lamei, H. Babazadeh, S.H. Afshar Yavari, Isolation of rapid growing mycobacteria from soil and water in Iran, Afr. J. Biotechnol. 9 (24) (2010) 3618–3621.  Back to cited text no. 16
    
17.
S. Rahideh, P. Farnia, M. Darbouy, Isolation and identification of rapidly growing mycobacteria from water and soil by PCR-RFLP method in Robat Karim (text in Persian), J. Health 4 (4) (2013) 321–329.  Back to cited text no. 17
    
18.
M. Saifi, E.A. Jabbarzadeh, R. Bahrmand, A. Karimi, S. Pourazar, A. Fateh, et al, HSP65-PRA identification of nontuberculosis mycobacteria from 4892 samples suspicious for mycobacterial infections, Clin. Microbiol. Infect. 19 (8) (2013) 723–728.  Back to cited text no. 18
    
19.
M. Shafipour, M. Ghane, S. Rahimi Alang, S. Livani, F. Shakeri, E.A. Ghaemi, Non tuberculosis mycobacteria isolated from tuberculosis patients in Golestan province, North of Iran, Ann. Biol. Res. 4 (12) (2013) 133–137.  Back to cited text no. 19
    
20.
P. Heidarieh, H. Shojaei, M.M. Feizabadi, A. Havei, A. Hashemi, et al, Molecular identification and conventional susceptibility testing of Iranian clinical Mycobacterium fortuitum isolates, Iran. J. Basic Med. Sci. 13 (1) (2010) 210–215.  Back to cited text no. 20
    
21.
H. Shojaei, A. Hashemi, P. Heidarieh, A. Daei-Naser, Chronic pelvic pain due to Mycobacterium parascrofulaceum in an Iranian patient: first report of isolation and molecular characterization from Asia, Braz. J. Infect. Dis. 15 (2) (2011) 186–187.  Back to cited text no. 21
    
22.
S. Zaker Bostanabad, P. Heidarieh, N. Sheikhi, M. Ghalami, S.H. Pour Azar, et al, Identification of clinical isolates of mycobacteria recovered from Iranian patients by phenotypic and molecular methods (text in Persian), New Cellular Mol. Biotechnol. J. 2 (7) (2012) 49–56.  Back to cited text no. 22
    
23.
M. Karami Mirabadi, R. Dibaj, A. Hashemi-Shahraki, A. Daei Naser, M.H. Shah Hosseini, H. Shojaei, Isolation and identification of non-tuberculosis Mycobacterium (atypic) from water in Isfahan (text in Persian), J. Microb. Biotechnol. 3 (11) (2012) 29–34.  Back to cited text no. 23
    
24.
M. Roayayi, K. Ghazisaidi, M. Jamshidian, M.J. Kajbaf, The abundance of non-tuberculous mycobacteria in tuberculosis suspected patients in Ahvaz (Text in Persian), J. Ahvaz Univ. Med. Sci. 21 (1995) 69–76.  Back to cited text no. 24
    
25.
A.A. Velayati, K. Ghazisaidi, A. Bashiri, Y. Dolati, M. Mohammadi, J. Stanford, The distribution of environmental mycobacteria in Gilan region (text in Persian), J. Med. Counc. Islam. Repub. Iran 11 (3) (1992) 173–179.  Back to cited text no. 25
    
26.
S. Hadifar, S. Moghim, H. Gasemian-Safaei, H. Fazeli, F. Farid, M. Moghoofei, et al, Identification of non-tuberculosis mycobacteria isolates by polymerase chain reactionrestriction enzyme analysis of 360-bp fragment of rpob gene, J. Isfahan Med. School 31 (226) (2014) 1–11.  Back to cited text no. 26
    
27.
A.M. Alaeen, A.Z. Alaeen, H. Alaeen, A case report of fish tank granuloma in Khomein, Arak Med. Univ. J. 14 (57) (2011) 113–117.  Back to cited text no. 27
    
28.
F. Babamahmoodi, A. Babamahmoodi, B. Nikkhahan, Review of Mycobacterium marinum infection reported from Iran and report of three new cases with sporotrichoid presentation, Iran. Red Crescent Med. J. 16 (2) (2014) 1–6.  Back to cited text no. 28
    
29.
S. Zaker Bostanabad, P. Salehian, A. Hashemi Shahraki, Isolation of Mycobacterium chelonae in the sputum and cervical lymph nodes of patient with metastatic breast cancer, Mycobact. Dis. 2 (1) (2012) 1–3.  Back to cited text no. 29
    
30.
P. Heidarieh, A. Hashemi-Shahraki, A.D. Khosravi, Mycobacterium arupense infection in HIV-infected patients from Iran, Int. J. STD AIDS 24 (6) (2013) 485–487.  Back to cited text no. 30
    
31.
B. Honarvar, H. Movahedan, M. Mahmoodi, F.M. Sheikholeslami, P. Farnia, Mycobacterium aurum keratitis: an unusual etiology of a sight-threatening infection, Braz. J. Infect. Dis. 16 (2) (2012) 204–208.  Back to cited text no. 31
    
32.
S.M. Hosseini Fard, M.R. Yossefi, B. Esfandiari, S.A. Sefidgar, Mycobacterium marinum as a cause of skin chronic granulomatous in the hand, Caspian J. Intern. Med. 2 (1)(2011) 198–200.  Back to cited text no. 32
    
33.
M. Golpour, M. Ghasemi, Nodules and bullae on the back of the hand with axillary spread. Diagnosis: fish tank or swimming pool granuloma, Indian J. Dermatol. Venereol. Leprol. 74 (5) (2008) 551.  Back to cited text no. 33
    
34.
M. Marjani, M. Farshidpour, P. Tabarsi, F.M. Sheikholslami, P. Farnia, Isolation of Mycobacterium branderi, an unusual species from an acute myelogenous leukemia patient, Avicenna J. Med. 4 (1) (2014) 17–19.  Back to cited text no. 34
    
35.
F. Pourahmad, H. Shojaei, P. Heidarieh, A. Khosravi, A. Hashemi, Report of two cases of Mycobacterium europaeum from Iran, Jpn. J. Infect. Dis. 65 (6) (2012) 539–541.  Back to cited text no. 35
    
36.
M. Shamaei, M. Marjani, P. Farnia, P. Tabarsi, D. Mansouri, Human infections due to Mycobacterium lentiflavum: first report in Iran, Iran. J. Microbiol. 2 (1) (2010) 29–31.  Back to cited text no. 36
    
37.
H. Shojaei, A. Hashemi, P. Heidarieh, N. Hosseini, A. Daei Naser, Chronic pulmonary disease due to Mycobacterium monacense infection: the first case from Iran, Ann. Lab. Med. 32 (1) (2012) 87–90.  Back to cited text no. 37
    
38.
M. Boloorsaz, S. Khalilzadeh, P. Farnia, S. Hakimi, A.A. Velayati, Mycobacterium thermoresistibile infection in a child, Tanaffos 5 (3) (2006) 61–63.  Back to cited text no. 38
    
39.
H. Shojaei, P. Heidarieh, A. Hashemi, M.M. Feizabadi, A. Daei Naser, Species identification of neglected nontuberculous mycobacteria in a developing country, Jpn. J. Infect. Dis. 64 (4) (2011) 265–271.  Back to cited text no. 39
    
40.
H. Shojaei, C. Daley, Z. Gitti, A. Hashemi, P. Heidarieh, I.R. Moore, et al, Mycobacterium iranicum sp. Nov., a rapidly growing scotochromogenic species isolated from clinical specimens on three different continents, Int. J. Syst. Evol. Microbiol. 63 (4) (2013) 1383–1389.  Back to cited text no. 40
    
41.
M. Gunaydin, K. Yanik, C. Eroglu, A. Sanic, I. Ceyhan, Z. Erturan, R. Durmaz, Distribution of nontuberculous mycobacteria strains, Ann. Clin. Microbiol. Antimicrob. 12 (33) (2013) 1–6.  Back to cited text no. 41
    
42.
A. Babalik, T. Kuyucu, E.N. Ordu, D. Ernam, M. Partal, K. Koksalan, Non-tuberculous mycobacteria infection: 75 cases, Tuberk Toraks 60 (1) (2012) 20–31.  Back to cited text no. 42
    
43.
C. Bicmen, A.T. Gunduz, M. Coskun, G. Senol, A.K. Cirak, A. Ozsoz, Molecular detection and identification of Mycobacterium tuberculosis complex and four clinically important nontuberculous mycobacterial species in smearnegative clinical samples by the genotype mycobacteria direct test, J. Clin. Microbiol. 49 (8) (2011) 2874.2878.  Back to cited text no. 43
    
44.
A. Ozbek, O. Aktas, Identification of three strains of Mycobacterium species isolated from clinical samples using fatty acid methyl ester profiling, J. Int. Med. Res. 31 (2) (2003) 133.140.  Back to cited text no. 44
    
45.
C. Bicmen, M. Coskun, A.T. Gunduz, G. Senol, A.K. Cirak, G. Tibet, Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not?, New Microbiol 33 (4) (2010) 399.403.  Back to cited text no. 45
    
46.
N. Albayrak, H. Simşek, F. Sezen, A. Arslantu N rk, G. Tarhan, I. Ceyhan, Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009.2010, Turkey, Mikrobiol. Bul. 46 (4) (2012) 560.567.  Back to cited text no. 46
    
47.
F.E. Aydin, M. Ulger, G. Emekdas, G. Aslan, S. Gunal, Isolation and identification of Mycobacterium bovis and nontuberculous mycobacteria in raw milk samples in Mersin province, Mikrobiol. Bul. 46 (2) (2012) 283.289.  Back to cited text no. 47
    
48.
M. Kanlikama, C. Oasahinoglu, E. Akan, K. Ozcan, Mycobacterial species causing cervicofacial infection in Turkey, Eur. Arch. Otorhinolaryngol. 250 (4) (1993) 237.239.  Back to cited text no. 48
    
49.
A. Ergin, T. Kocagoz, D. Us, Evaluation of 120 mycobacterial strains isolated from clinical specimens to the species level by polymerase chain reaction-restriction enzyme analysis, Scand. J. Infect. Dis. 32 (6) (2000) 657.662.   Back to cited text no. 49
    
50.
A. Agacayak, Y. Bulut, A. Seyrek, Detection of Mycobacterium species distribution in the sputum samples of tuberculosis patients by PCR-RFLP method in Elazig province, Mikrobiol. Bu N l. 41 (2) (2007) 203.209.  Back to cited text no. 50
    
51.
G.E. Genc, E. Richter, Z. Erturan, Isolation of nontuberculous mycobacteria from hospital waters in Turkey, Acta Pathol. Microbiol. Immunol. Scandinivica 121 (12) (2013) 1192.1197.  Back to cited text no. 51
    
52.
U. Cafri, G. Aslan, S. Direkel, G. Tarhan, I. Ceyhan, G. Emekdas, Identification and isolation of non-tuberculous mycobacteria from environmental samples, Mikrobiyoloji Bu N lteni 44 (3) (2010) 395.403.  Back to cited text no. 52
    
53.
M. Konuk, E. Korcan, S. Dülgerbaki, M. Altındiş, Isolation and identification of mycobacteria from raw milk samples in Afyonkarahisar district of Turkey, Int. J. Food Microbiol. 115 (3) (2007) 343.347.  Back to cited text no. 53
    
54.
K.K. Yasar, F. Pehlivanoglu, G. Sengoz, N. Cabioglu, Successfully treated Mycobacterium abscessus mastitis: a rare cause of breast masses, Indian J. Med. Microbiol. 29 (4) (2011) 425.427.  Back to cited text no. 54
    
55.
V. Yazisiz, F. Erbasan, D. Inan, G. Ongut, B.K. Akkaya, et al, Bone marrow infection caused by Mycobacterium avium complex in a patient with systemic lupus erythematosus, Lupus 19 (3) (2010) 323.326.  Back to cited text no. 55
    
56.
H.T. Sanal, F. Zor, M. Kocaog. lu, N. Bulakbaşi, Atypical mycobacterial tenosynovitis and bursitis of the wrist, Diagn. Interv. Radiol. 15 (4) (2009) 266.268.  Back to cited text no. 56
    
57.
B. Ergan, L. Coplu, A. Alp, M. Artvinli, Mycobacterium smegmatis Pneumonia, Respirology 9 (2) (2004) 283.285.  Back to cited text no. 57
    
58.
G. Aksu, C. Tirpan, C. Cavusoglu, S. Soydan, F. Altar, et al, Mycobacterium fortuitum.chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency, Pediatr. Infect. Dis. 20 (5) (2001) 551.553.  Back to cited text no. 58
    
59.
Z.P. Onen, Z.C. Karahan, O. Akkoca Yildiz, G. Karabiyikoglu, Mycobacterium simiae infection in an immunocompetent patient, with DNA analyses verification, Tu N berk. Toraks Derg. 58 (3) (2010) 306.310.  Back to cited text no. 59
    
60.
I. Ceyhan, G. Tarhan, S. Cesur, F. Gumuslu, Mycobacterium chelonae keratitis following laser in situ keratomileusis (LASIK) specifically identified by INNO-LIPA method, Turk. J. Med. Sci. 35 (4) (2005) 273.277.  Back to cited text no. 60
    
61.
N. Edeer Karaca, S. Boisson-Dupuis, G. Aksu, J. Bustamante, G. Kandiloglu, N. Ozsan, et al, Granulomatous skin lesions, severe scrotal and lower limb edema due to mycobacterial infections in a child with complete IFN-c receptor-1 deficiency, Immunotherapy 4 (11) (2012) 1121–1127.  Back to cited text no. 61
    
62.
S.O. Wali, M.M. Abdelaziz, A.B. Krayem, Y.S. Samman, A.N. Shukairi, S.A. Mirdad, et al, The presence of atypical mycobacteria in the mouthwashes of normal subjects: role of tap water and oral hygiene, Ann. Thorac. Med. 3 (1) (2008) 5–8.  Back to cited text no. 62
    
63.
B. Varghese, Z. Memish, N. Abuljadayel, R. Al-Hakeem, F. Alrabiah, S.A. Al-Hajoj, Emergence of clinically relevant non-tuberculous mycobacterial infections in Saudi Arabia, Plos Negl. Trop. Dis. 7 (5) (2013) 2234–2238.  Back to cited text no. 63
    
64.
R. Zaman, Tuberculosis in Saudi Arabia: epidemiology and incidence of Mycobacterium tuberculosis and other mycobacterial species, Tubercle 72 (1) (1991) 43–49.  Back to cited text no. 64
    
65.
A.M. Somily, A.R. Al-Anazi, H.A. Babay, A.I. Al-Aska, M.A. Al- Hedaithy, W.K. Al-Hamoudi, et al, Mycobacterium chelonae complex bacteremia from a post-renal transplant patient, Jpn. J. Infect. Dis. 63 (1) (2010) 61–64.  Back to cited text no. 65
    
66.
A.N. Meshikhes, A. Al-Gassab, L.Y. Al-Jaffar, M. Tinguria, Z.S. Al-Meer, F. Borgio, Atypical mycobacteria: an unusual cause of breast abscess, Ann. Saudi Med. 17 (3) (1997) 337–339.  Back to cited text no. 66
    
67.
B. Varghese, S.E. Shajan, M.O. Al Saedi, S.A. Al-Hajoj, First case report of chronic pulmonary lung disease caused by Mycobacterium abscessus in two immunocompetent patients in Saudi Arabia, Ann. Saudi Med. 32 (3) (2012) 312–314.  Back to cited text no. 67
    
68.
M.A. Enani, H.H. Frayha, A.A. Halim, An appendiceal abscess due to Mycobacterium kansasii in a child with AIDS, Clin. Infect. Dis. 27 (4) (1998) 891–892.  Back to cited text no. 68
    
69.
R. AlKhodair, S. Al-Khenaizan, Fish tank granuloma: misdiagnosed as cutaneous leishmaniasis, Int. J. Dermatol. 49 (2010) 53–55.  Back to cited text no. 69
    
70.
S. Wali, Mycobacterium chelonae empyema with bronchopleural fistula in an immunocompetent patient, Ann. Thorac. Med. 4 (4) (2009) 213–215.  Back to cited text no. 70
    
71.
A.F. Al-Mobeireek, Rapidly growing mycobacterial pulmonary infection in association with severe gastroesophageal reflux disease, Saudi Med. J. 23 (7) (2002) 854–856.  Back to cited text no. 71
    
72.
F.M. Al Majid, Peritonitis due to Mycobacterium fortuitum following gastric banding, Saudi J. Gastroenterol. 16 (2) (2010) 113–115.  Back to cited text no. 72
    
73.
N. Siddiqi, I. Sheikh, Peritonitis caused by Mycobacterium abscesses in patients on continuous ambulatory peritoneal dialysis, Saudi J. Kidney Dis. Transplant. 23 (2) (2012) 321– 324.  Back to cited text no. 73
    
74.
M.A. Simbli, F.A. Niaz, J.S. Al-Wakeel, Encapsulating peritoneal sclerosis in a peritoneal dialysis patient presenting with complicated Mycobacterium fortuitum peritonitis, Saudi J. Kidney Dis. Transplant. 23 (3) (2012) 635– 641.  Back to cited text no. 74
    
75.
A.U. Syed, R. Hussain, A.N. Bhat, M. al Rasheed, H. al Qethami, et al, Mediastinitis due to Mycobacterium fortuitum infection following Fontan operation in a child, Scand. Cardiovasc. J. 31 (5) (1997) 311–313.  Back to cited text no. 75
    
76.
A.M. Hakawi, A.A. Alrajhi, Septic arthritis due to Mycobacterium szulgai in a patient with human immunodeficiency virus, Scand. J. Infect. Dis. 37 (3) (2005) 235–237.  Back to cited text no. 76
    
77.
S.H. Annobil, G.A. Jamjoom, R. Bobo, J. Iyengar, Fatal lipoid pneumonia in an infant complicated by Mycobacterium fortuitum infection, Trop. Geogr. Med. 44 (1–2) (1992) 160–164.  Back to cited text no. 77
    
78.
H.I. Hakami, A.A. Alhazmi, A.A. Alrajhi, Mycobacterium abscessus peritonitis associated with laparoscopic gastric banding, BMC Infect. Dis. 13 (2013) 323.  Back to cited text no. 78
    
79.
H. Almoallim, L. Alharbi, Z. Alshareef, G. Wali, Case of erosive polyarthritis in a patient diagnosed with a suspicion of atypical mycobacteria, Open Rheumatol. J. 28 (7) (2013) 64–66.  Back to cited text no. 79
    
80.
O. Abbas, N. Marrouch, M.M. Kattar, S. Zeynoun, A.G. Kibbi, R.A. Rached, et al, Cutaneous non-tuberculous mycobacterial infections: a clinical and histopathological study of 17 cases from Lebanon, J. Eur. Acad. Dermatol. Venereol. 25 (1) (2011) 33–42.  Back to cited text no. 80
    
81.
R. Pinto-Powell, K.N. Olivier, B.J. Marsh, S. Donaldson, H. Worth Parker, W. Boyle, et al, Skin testing with Mycobacterium avium sensitin to identify infection with M. avium complex in patients with cystic fibrosis, Clin. Infect. Dis. 22 (3) (1996) 560–562.  Back to cited text no. 81
    
82.
F.M.T. Lewis, B.J. Marsh, C.F. von Reyn, Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention, Clin. Infect. Dis. 37 (3) (2003) 390–397.  Back to cited text no. 82
    
83.
R.N. Hamam, B. Noureddin, H.I. Salti, R. Haddad, J.M. Khoury, Recalcitrant post-LASIK Mycobacterium chelonae Keratitis eradicated after the use of fourth-generation fluoroquinolone, Ophthalmology 113 (6) (2006) 950–954.  Back to cited text no. 83
    
84.
M.M. Balkis, M.M. Kattar, G.F. Araj, S.S. Kanj, Fatal disseminated Mycobacterium simiae infection in a non-HIV patient, Int. J. Infect. dis. 13 (5) (2009) 286–287.  Back to cited text no. 84
    
85.
L.N. Jarikre, Case report: disseminated Mycobacterium gordonae infection in a nonimmuno compromised host, Am. J. Med. Sciences 302 (6) (1991) 382–384.  Back to cited text no. 85
    
86.
L.N. Jarikre, Mycobacterium gordonae genitourinary disease, Genitourin. Med. 68 (1) (1992) 45–46.  Back to cited text no. 86
    
87.
H. Al Soub, M. Al Maslamani, J. Al Khuwaiter, Y. El Deeb, M. Abu Khattab, Myocardial abscess and bacteremia complicating Mycobacterium fortuitum pacemaker infection: case report and review of the literature, Pediatr. Infect. Dis. J. 28 (11) (2009) 1032–1034.  Back to cited text no. 87
    
88.
H. Al Soub, E. Al-Maslamani, M. Al-Maslamani, Mycobacterium fortuitum abdominal wall abscesses following liposuction, Indian J. Plast. Surg. 41 (1) (2008) 58–61.  Back to cited text no. 88
    
89.
I. Ahmed, K. Jabeen, R. Hasan, Identification of nontuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital: a cross-sectional study, BMC Infect. Dis. 13 (493) (2013) 1–7.  Back to cited text no. 89
    
90.
T. Khanum, S.A. Rasool, M. Ajaz, A.I. Khan, Isolation-drug resistance profile and molecular characterization of indigenous typical and atypical mycobacteria, Pak. J. Pharm. Sci. 24 (4) (2011) 527–532.  Back to cited text no. 90
    
91.
N. Akhtar, A. Bari, K. Nomani, Incidence of typical and a typical mycobacteria in pulmonary infections at Lahore – a study of 500 cases, J. Pak. Med. Assoc. 34 (4) (1984) 84–87.  Back to cited text no. 91
    
92.
A. Afzal, M. Nadeem, S. Aman, A.H. Kazmi, Mycobacterium marinum infection: A case report, J. Pak. Assoc. Dermatol. 97 (2009) 48–51.  Back to cited text no. 92
    
93.
K.I. Hassan, A.A. Ali, Detection of Mycobacterium avium in milk powder using species specific pcr, Int. J. Adv. Sci. Eng. Technol. 2 (2) (2012) 115–119.  Back to cited text no. 93
    
94.
A.A. Al-Sulami, A.M.R. Al-Taee, Q.H. Wida'a, Isolation and identification of Mycobacterium avium complex and other nontuberculosis mycobacteria from drinking-water in Basra governorate, Iraq, East. Mediterr. Health J. 18 (3) (2012) 274– 278.  Back to cited text no. 94
    
95.
A.M. Hamzah, Mycobacterium Spp. isolated from horses fecal samples, Int. J. Med. Pharm. Sci. 3 (3) (2013) 23–28.  Back to cited text no. 95
    
96.
M.A. El-Khalawany, Atypical mycobacterial cutaneous infections in Egyptians: a clinicopathological study, J. Dermatol. 41 (4) (2014) 303–310.  Back to cited text no. 96
    
97.
G. Bamias, G.L. Daikos, S.I. Siakavellas, G. Kaltsa, S. Smilakou, I. Katsogridakis, et al, Atypical mycobacterial infection presenting as persistent skin lesion in a patient with ulcerative colitis, Case Rep. Med. 2011 (2011) 1–4.  Back to cited text no. 97
    
98.
S. Godreuil, H. Marchandin, A.L. Michon, M. Ponsada, G. Chyderiotis, P. Brisou, et al, Mycobacterium riyadhense pulmonary infection France and Bahrain, Emerg. Infect. Dis. 18 (1) (2012) 176–178.  Back to cited text no. 98
    
99.
S. Alkhawaja, N. Tammam, N. Khalifa, Mycobacterium marinum infection after infliximab therapy, Iran. J. Allergy Asthma Immunol. 9 (2010) 255–257.  Back to cited text no. 99
    
100.
E. Mokaddas, S. Ahmad, Species spectrum of nontuberculous mycobacteria isolated from clinical specimens in Kuwait, Curr. Microbiol. 56 (5) (2008) 413–417.  Back to cited text no. 100
    
101.
K. Al-Benwan, S. Ahmad, E. Mokaddas, M. Johny, M.M. Kapoor, Diagnosis of endocarditis caused by Mycobacterium abscessus, Ann. Saudi Med. 30 (5) (2010) 408–411.  Back to cited text no. 101
    
102.
S.H. Al-Mahruqi, J. van Ingen, S. Al-Busaidy, M.J. Boeree, S. Al-Zadjali, A. Patel, et al, Clinical relevance of nontuberculous mycobacteria, Oman, Emerg. Infect. Dis. J. 15 (2) (2009) 292–294.  Back to cited text no. 102
    
103.
K.L. Winthrop, E. Chang, S. Yamashita, M.F. Iademarco, P.A. Lobue, Nontuberculous mycobacteria infections and antitumor necrosis factor – a therapy, Emerg. Infect. Dis. 15 (10) (2009) 1556–1561.  Back to cited text no. 103
    
104.
K. Gopinath, S. Singh, Non-tuberculous mycobacteria in tbendemic countries: are we neglecting the danger?, PLoS 4 (4) (2010) 1–4.  Back to cited text no. 104
    
105.
E. Tortoli, P.G. Rogasi, E. Fantoni, C. Beltrami, A. De Francisci, A. Mariottini, Infection due to a novel mycobacterium, mimicking multidrug-resistant Mycobacterium tuberculosis, Clin. Microbiol. Infect. 16 (8) (2010) 1130–1134.  Back to cited text no. 105
    
106.
B. Springer, L. Stockman, K. Teschner, G.D. Roberts, E.C. Bö ttger, Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods, J. Clin. Microbiol. 34 (2) (1996) 296–303.  Back to cited text no. 106
    
107.
L. Dvorska, M. Bartos, G. Martin, W. Erler, I. Pavlik, Strategies for differentiation, identification and typing of medically important species of mycobacteria by molecular methods, Vet. Med. 46 (11–12) (2001) 309–328.  Back to cited text no. 107
    
108.
E. Wolisky, T.K. Rynearson, Mycobacteria in soil and their relation to disease associated strains, Am. Rev. Respir. Dis. 97 (6) (1968) 1032–1037.  Back to cited text no. 108
    
109.
S. Goslee, E. Wolisky, Water as a source of potentially pathogenic mycobacteria, Am. Rev. Respir. Dis. 113 (3) (1976) 287–292.  Back to cited text no. 109
    
110.
T.H. Brown, The rapidly growing mycobacteria: Mycobacterium fortuitum and Mycobacterium chelonei, Infect. Control 6 (1985) 283–288.  Back to cited text no. 110
    
111.
S.C. Yang, P.R. Hsueh, H.C. Lai, L.J. Teng, L.M. Huang, J.M. Chen, et al, High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan, Antimicrob. Agents Chemother. 47 (6) (2003) 958–1962.  Back to cited text no. 111
    
112.
J.M. Lim, J.H. Kim, H.J. Yang, Management of infections with rapidly growing mycobacteria after unexpected complications of skin and subcutaneous surgical procedures, Arch. Plast. Surg. 39 (1) (2012) 18–24.  Back to cited text no. 112
    
113.
D.E. Griffith, T.B. Aksamit, A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, et al, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am. J. Respir. Crit. Care Med. 175 (2007) 367–416.  Back to cited text no. 113
    
114.
N. Martín-Casabona, A.R. Bahrmand, J. Bennedsen, V.O. Thomsen, M. Curcio, M. Fauville-Dufaux, et al, Nontuberculous mycobacteria: patterns of isolation. A multicountry retrospective survey, Int. J. Tuberc. Lung. Dis. 8 (10) (2004) 1186–1193.  Back to cited text no. 114
    
115.
M. Mirsaidi, M. Farshidpour, G. Ebrahimi, S. Aliberti, J.O. Falkinham III, Management of nontuberculous mycobacterial infection in the elderly, Eur. J. Intern. Med. 25 (4) (2014) 356–363.  Back to cited text no. 115
    
116.
S.K. Field, D. Fisher, R.L. Cowie, Mycobacterium avium complex pulmonary disease in patients without HIV infection, Chest 126 (2) (2004) 566–581.  Back to cited text no. 116
    
117.
P. Baghaei, P. Tabarsi, P. Farnia, M. Marjani, F.M. Sheikholeslami, M. Chitsaz, et al, Pulmonary disease caused by Mycobacterium simiae in Iran's national referral center for tuberculosis, J. Infect. Dev. Ctries. 6 (1) (2012) 23– 28.  Back to cited text no. 117
    
118.
V. Lévy-Frébault, B. Pangon, A. Buré , C. Katlama, C. Marche, H.L. David, Mycobacterium simiae and Mycobacterium avium- M. intracellular mixed infection in acquired immune deficiency syndrome, J. Clin. Microbiol. 25 (1) (1987) 154–157.  Back to cited text no. 118
    
119.
N. Sriyabhaya, S. Wongwatana, Pulmonary infection caused by atypical mycobacteria: a report of 24 cases in Thailand, Rev. Infect. Dis. 3 (5) (1981) 1085–1089.  Back to cited text no. 119
    
120.
J. Canueto-Quintero, F.J. Caballero-Granado, M. Herrero- Romero, Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study, Clin. Infect. Dis. 37 (4) (2003) 584–590.  Back to cited text no. 120
    
121.
M.V. Leal Arranz, A. Gaafar, M.J. Unzaqa Barañ ano, J.A. Crespo Notario, R. Cisterna Cáncer, F. García Cebriá n, Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain, Arch. Bronconeumol. 41 (4) (2005) 189–196.  Back to cited text no. 121
    
122.
J.L. Cook, Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts, Br. Med. Bull. 96 (2010) 45–59.  Back to cited text no. 122
    
123.
M. Dailloux, M.L. Abalain, C. Laurain, L. Lebrun, C. Loos- Ayav, et al, Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients, Eur. Resp. J. 28 (6) (2006) 1211–1215.  Back to cited text no. 123
    
124.
M.D. Yates, J.M. Grange, C.H. Colins, The nature of mycobacterial disease in southeast England, 1977–84, J. Epidemiol. Commun. Health 40 (1986) 295–330.  Back to cited text no. 124
    
125.
E.E. Bodle, J.A. Cunningham, P.N. Della-Latta, W. Schluger, L. Saiman, Epidemiology of nontuberculous mycobacteria in patients without HIV infection, Emerg. Infect. Dis. 14 (3) (2008) 390–396.  Back to cited text no. 125
    
126.
V.O. Thomsen, A.B. Andersen, H. Miö rner, Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey, Scand. J. Infect. Dis. 34 (9) (2002) 648–653.  Back to cited text no. 126
    
127.
K. Lenart, A. Sajduda, E. Augustynowicz-Kopec, J. Dziadek, Profiling Mycobacterium xenopi with restriction fragment length polymorphism of insertion element IS1395, Int. J. Infect. dis. 15 (5) (2011) 321–325.  Back to cited text no. 127
    
128.
A.H. Shahraki, P. Heidarieh, M. Drancourt, M. Hashemzadeh, S. Khandan, et al, Infection caused by an unusual isolate of non-tuberculosis mycobacteria in Iran, Int. J. Mycobacteriol. 4 (S1) (2014) 162.  Back to cited text no. 128
    
129.
M.A. De Groote, G. Huitt, Infections due to rapidly growing mycobacteria, Clin. Infect. Dis. 42 (15) (2006) 1756–1763.  Back to cited text no. 129
    
130.
G. Ebrahimi, M. Farshidpour, M.B. Allen, M. Mirsaeidi, J.O. Falkinham III, Nontuberculous mycobacterial disease in North America, Int. J. Mycobacteriol. 4 (S1) (2014) 154–155.  Back to cited text no. 130
    
131.
M. Al-Knawy, W. Bosch, H. Garner, M. Mirsaeidi, J. Cawley, P. Murray, et al, A descriptive analysis of nontuberculous mycobacterial infections (NTM) of the upper extremity, Int. J. Mycobacteriol. 4 (S1) (2014) 37–38.  Back to cited text no. 131
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]


This article has been cited by
1 BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity
Getahun Abate,Fahreta Hamzabegovic,Christopher S. Eickhoff,Daniel F. Hoft
Frontiers in Immunology. 2019; 10
[Pubmed] | [DOI]
2 Mycobacterium avium complex pulmonary disease
Leah Lande,Jason George,Theodore Plush
Current Opinion in Infectious Diseases. 2018; : 1
[Pubmed] | [DOI]
3 Comparison of polymerase chain reaction-restriction enzyme analysis method and DNA sequence analysis results in the identification of non-tuberculous mycobacteria
Özgür Appak,Selçuk Türkel,Nuran Esen,Ayse Aydan Özkütük
Acta Microbiologica et Immunologica Hungarica. 2018; 65(4): 515
[Pubmed] | [DOI]
4 High rates of Mycobacterium fortuitum isolation in respiratory samples from Iranian patients with suspected tuberculosis: is it clinically important?
Mahsa Irandoost,Mehrnoosh Zare Ghanbari,Fatemeh Sakhaee,Farzam Vaziri,Fatemeh Rahimi Jamnani,Seyed Davar Siadat,Abolfazl Fateh
Journal of Medical Microbiology. 2018;
[Pubmed] | [DOI]
5 Esophageal Mycobacterium avium-intracellulare infection in a bone marrow transplant patient: Case report and literature review
Rong Hou,Ravi Nayak,Steven M. Pincus,Jinping Lai,Louay M. Omran,Samer Alkaade,Getahun Abate
Transplant Infectious Disease. 2018; : e13019
[Pubmed] | [DOI]
6 Genetic Diversity and Prevalence of Nontuberculous Mycobacteria Isolated from Clinical Samples in Tehran, Iran
Mehdi Davari,Mahsa Irandoost,Fatemeh Sakhaee,Farzam Vaziri,Abbas Akhavan Sepahi,Fatemeh Rahimi Jamnani,Seyed Davar Siadat,Abolfazl Fateh
Microbial Drug Resistance. 2018;
[Pubmed] | [DOI]
7 Nontuberculous Mycobacteria in Saudi Arabia and Gulf Countries: A Review
Hawra Al-Ghafli,Sahal Al-Hajoj
Canadian Respiratory Journal. 2017; 2017: 1
[Pubmed] | [DOI]
8 Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea
Hee Jung Yoon,Hwa Young Choi,Moran Ki
BMC Infectious Diseases. 2017; 17(1)
[Pubmed] | [DOI]
9 Computed Tomography Findings of Pulmonary Mycobacterium simiae Infection
Ayeh Baghizadeh,Payam Mehrian,Poopak Farnia
Canadian Respiratory Journal. 2017; 2017: 1
[Pubmed] | [DOI]
10 Distribution of non-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat shock protein 65 PCR–RFLP
Ali Nour-Neamatollahie,Nayereh Ebrahimzadeh,Seyed Davar Siadat,Farzam Vaziri,Mona Eslami,Abbas Akhavan Sepahi,Sharareh Khanipour,Morteza Masoumi,Fatemeh Sakhaee,Morteza Ghazanfari Jajin,Ahmadreza Bahrmand,Abolfazl Fateh
Saudi Journal of Biological Sciences. 2016;
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Methods
Results
Discussion
Conclusion
Conflict of inte...
Acknowledgements
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed903    
    Printed35    
    Emailed0    
    PDF Downloaded114    
    Comments [Add]    
    Cited by others 10    

Recommend this journal